Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease

Aim. Implantable cardioverter­defibrillator (ICD) implantation technique optimization in patients with coronary artery disease (CAD) in order to reduce fluoroscopy time and total radiation dose to staff.Material and methods. Patients with CAD and indications for the ICD implantation were examined. P...

Full description

Saved in:
Bibliographic Details
Main Authors: T. A. Atabekov, R. E. Batalov, S. N. Krivolapov, M. S. Khlynin, S. I. Sazonova, A. D. Shvarzman, G. Zh. Suranova, S. V. Popov
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2018-12-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/2739
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849341534258855936
author T. A. Atabekov
R. E. Batalov
S. N. Krivolapov
M. S. Khlynin
S. I. Sazonova
A. D. Shvarzman
G. Zh. Suranova
S. V. Popov
author_facet T. A. Atabekov
R. E. Batalov
S. N. Krivolapov
M. S. Khlynin
S. I. Sazonova
A. D. Shvarzman
G. Zh. Suranova
S. V. Popov
author_sort T. A. Atabekov
collection DOAJ
description Aim. Implantable cardioverter­defibrillator (ICD) implantation technique optimization in patients with coronary artery disease (CAD) in order to reduce fluoroscopy time and total radiation dose to staff.Material and methods. Patients with CAD and indications for the ICD implantation were examined. Patients were divided into two groups. In first group before ICD implantation, patients underwent cardiac 99mTc­methoxy­isobutyl­isonitrile scintigraphy for right ventricle wall perfusion disorders assessment. In this group defibrillating lead was implanted to the septal position, if the perfusion disorders were in the apical segments, and to the apical position, if perfusion disorders were in the septal segment. In second group lead was implanted using conventional approach. Fluoroscopy duration and radiation dose were compared.Results. There were 58 patients (male­52, female­6, age­64,5±8,5 years) enrolled. The first group consisted of 27 (46,5%) patients. For 13 (48,1%) patient ICD was implanted for primary, and 14 (51,9%) one for secondary sudden cardiac death (SCD) prevention. In 14 (51,9%) cases in this group defibrillating lead was implanted to the apical and in 13 (48,1%) — to the septal position. The 2­nd group consisted of 31 (53,5%) patients. For 13 (41,9%) patient ICD was implanted for primary, and 18 (58,1%) one for secondary SCD prevention. In 15 (48,3%) cases in this group defibrillating lead was implanted to the apical and in 16 (51,7%) — to the septal position. There were significant differences between groups in terms of fluoroscopy duration  — 85,5±28,1 and 131,6±53,5 sec (р=0,0001) and radiation dose — 0,14±0,07 and 0,21±0,08 (p=0,0004) mSv, respectively.Conclusion. Assessment of right ventricular perfusion before ICD implantation reduce fluoroscopy time and total radiation exposure to staff.
format Article
id doaj-art-c10f1e609786430aafe66442e4d3560e
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2018-12-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-c10f1e609786430aafe66442e4d3560e2025-08-20T03:43:36Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202018-12-01011656910.15829/1560-4071-2018-11-65-692403Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery diseaseT. A. Atabekov0R. E. Batalov1S. N. Krivolapov2M. S. Khlynin3S. I. Sazonova4A. D. Shvarzman5G. Zh. Suranova6S. V. Popov7Tomsk National Research Medical Center RAS.Tomsk National Research Medical Center RAS.Tomsk National Research Medical Center RAS.Tomsk National Research Medical Center RAS.Tomsk National Research Medical Center RAS.Tomsk National Research Medical Center RAS.Pathological Physiology Department, International School of Medicine.Tomsk National Research Medical Center RAS.Aim. Implantable cardioverter­defibrillator (ICD) implantation technique optimization in patients with coronary artery disease (CAD) in order to reduce fluoroscopy time and total radiation dose to staff.Material and methods. Patients with CAD and indications for the ICD implantation were examined. Patients were divided into two groups. In first group before ICD implantation, patients underwent cardiac 99mTc­methoxy­isobutyl­isonitrile scintigraphy for right ventricle wall perfusion disorders assessment. In this group defibrillating lead was implanted to the septal position, if the perfusion disorders were in the apical segments, and to the apical position, if perfusion disorders were in the septal segment. In second group lead was implanted using conventional approach. Fluoroscopy duration and radiation dose were compared.Results. There were 58 patients (male­52, female­6, age­64,5±8,5 years) enrolled. The first group consisted of 27 (46,5%) patients. For 13 (48,1%) patient ICD was implanted for primary, and 14 (51,9%) one for secondary sudden cardiac death (SCD) prevention. In 14 (51,9%) cases in this group defibrillating lead was implanted to the apical and in 13 (48,1%) — to the septal position. The 2­nd group consisted of 31 (53,5%) patients. For 13 (41,9%) patient ICD was implanted for primary, and 18 (58,1%) one for secondary SCD prevention. In 15 (48,3%) cases in this group defibrillating lead was implanted to the apical and in 16 (51,7%) — to the septal position. There were significant differences between groups in terms of fluoroscopy duration  — 85,5±28,1 and 131,6±53,5 sec (р=0,0001) and radiation dose — 0,14±0,07 and 0,21±0,08 (p=0,0004) mSv, respectively.Conclusion. Assessment of right ventricular perfusion before ICD implantation reduce fluoroscopy time and total radiation exposure to staff.https://russjcardiol.elpub.ru/jour/article/view/2739cardioverter­defibrillatorfluoroscopy timeradiation exposure to staff99mtc­methoxy­isobutyl­isonitriledefibrillating lead
spellingShingle T. A. Atabekov
R. E. Batalov
S. N. Krivolapov
M. S. Khlynin
S. I. Sazonova
A. D. Shvarzman
G. Zh. Suranova
S. V. Popov
Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
Российский кардиологический журнал
cardioverter­defibrillator
fluoroscopy time
radiation exposure to staff
99mtc­methoxy­isobutyl­isonitrile
defibrillating lead
title Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
title_full Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
title_fullStr Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
title_full_unstemmed Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
title_short Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
title_sort reducing fluoroscopy time during cardioverter defibrillator implantation performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
topic cardioverter­defibrillator
fluoroscopy time
radiation exposure to staff
99mtc­methoxy­isobutyl­isonitrile
defibrillating lead
url https://russjcardiol.elpub.ru/jour/article/view/2739
work_keys_str_mv AT taatabekov reducingfluoroscopytimeduringcardioverterdefibrillatorimplantationperformedwithconsideringofmyocardiumperfusionscintigraphyresultsinpatientswithcoronaryarterydisease
AT rebatalov reducingfluoroscopytimeduringcardioverterdefibrillatorimplantationperformedwithconsideringofmyocardiumperfusionscintigraphyresultsinpatientswithcoronaryarterydisease
AT snkrivolapov reducingfluoroscopytimeduringcardioverterdefibrillatorimplantationperformedwithconsideringofmyocardiumperfusionscintigraphyresultsinpatientswithcoronaryarterydisease
AT mskhlynin reducingfluoroscopytimeduringcardioverterdefibrillatorimplantationperformedwithconsideringofmyocardiumperfusionscintigraphyresultsinpatientswithcoronaryarterydisease
AT sisazonova reducingfluoroscopytimeduringcardioverterdefibrillatorimplantationperformedwithconsideringofmyocardiumperfusionscintigraphyresultsinpatientswithcoronaryarterydisease
AT adshvarzman reducingfluoroscopytimeduringcardioverterdefibrillatorimplantationperformedwithconsideringofmyocardiumperfusionscintigraphyresultsinpatientswithcoronaryarterydisease
AT gzhsuranova reducingfluoroscopytimeduringcardioverterdefibrillatorimplantationperformedwithconsideringofmyocardiumperfusionscintigraphyresultsinpatientswithcoronaryarterydisease
AT svpopov reducingfluoroscopytimeduringcardioverterdefibrillatorimplantationperformedwithconsideringofmyocardiumperfusionscintigraphyresultsinpatientswithcoronaryarterydisease